Britannia Life Sciences Inc. (CNSX:BLAB) entered into an agreement to acquire additional 10% stake in Advanced Development & Safety Laboratories Limited on April 7, 2022. Upon completion of the Additional ADSL Purchase, Britannia will own a 70% interest in ADSL, Britannia's largest operating subsidiary. Gowling WLG (UK) LLP and Bennett Jones LLP acted as legal advisor to Britannia Life Sciences Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.065 CAD | 0.00% | -18.75% | -13.33% |
1st Jan change | Capi. | |
---|---|---|
-13.33% | 7.71M | |
+15.09% | 8.35B | |
+3.37% | 7.62B | |
+1.45% | 6.01B | |
-6.26% | 3.75B | |
-9.86% | 3.7B | |
-6.55% | 1.34B | |
-28.83% | 1.13B | |
+14.31% | 992M | |
-10.78% | 925M |
- Stock Market
- Equities
- BLAB Stock
- News Britannia Life Sciences Inc.
- Britannia Life Sciences Inc. entered into an agreement to acquire additional 10% stake in Advanced Development & Safety Laboratories Limited.